NCT05772637 Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
| NCT ID | NCT05772637 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Overactive Bladder |
| Study Type | INTERVENTIONAL |
| Enrollment | 113 participants |
| Start Date | 2024-02-14 |
| Primary Completion | 2027-02-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 113 participants in total. It began in 2024-02-14 with a primary completion date of 2027-02-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to assess the association between bladder sensations progression during bladder filling and severity of Overactive bladder (OAB) in patients with multiple sclerosis.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 * MS according to the 2017 Mac Donald diagnostic criteria * Bladder disorders supposedly related to MS * Indication to perform urodynamics * No current medication for bladder disorders * Able to understand and right in French * Affiliated to the "Securite sociale" or "Couverture Medicale Universelle (CMU)", or equivalent organism. Exclusion criteria: * Legal protection * Pregnancy or breastfeeding mother * MS relapse during the past month * Other associated neurological disease * Genuine stress incontinence related to postpartum * Treatment with antimuscarinics, alpha blockers, beta3 adrenergic, or tibial nerve stimulation in the past 15 days, or with botulinic toxin injection in the past 6 months * Previous lower urinary tract surgery * Inability to use the analogic device due to motor, sensory or ataxic disabilities
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05772637 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Overactive Bladder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05772637 currently recruiting?
Yes, NCT05772637 is actively recruiting participants. Contact the research team at claire.hentzen@aphp.fr for enrollment information.
Where is the NCT05772637 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT05772637 clinical trial?
NCT05772637 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 113 participants.